跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
THIOTEPA-REACH thiotepa 15 mg powder for injection vial
Approved
STANDARD
THIOTEPA-REACH thiotepa 15 mg powder for injection vial
Reach Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
c5c5af411817f67f
Company
Reach Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
c5c5af411817f67f
Product Name
THIOTEPA-REACH thiotepa 15 mg powder for injection vial
Artg Id
364527
Artg Name
THIOTEPA-REACH thiotepa 15 mg powder for injection vial
Sponsor
Reach Pharmaceuticals Pty Ltd
Company Detail Path
/organization/reach-pharmaceuticals-pty-ltd
Artg Date
2022-06-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/b1a71c105a9dbbaf5b1cc50525f43fcb.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/2a87bd8a0fb9c1726092744f1cd3a1fd.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
c5c5af411817f67f
Type
Standard
Back to TGA Approvals
THIOTEPA-REACH thiotepa 15 mg powder for injection vial - TGA Drug Approval Details